141st APHA Annual Meeting

In This section

278743
Toward integrated care: How brief screening tools can help identify and address alcohol use and depression comorbidity

Tuesday, November 5, 2013 : 10:50 AM - 11:10 AM

Jonathan Agley, PhD, MPH , School of Public Health, Indiana University, Bloomington, Indiana University, Bloomington, IN
Richard Goldsworthy, PhD, MSEd , Academic Edge, Inc., Bloomington, IN
Dean Babcock, LCSW, ACSW , Midtown Community Mental Health Center, Indianapolis, IN
Joseph Bartholomew, MSW, LCAC, CHES , Coordinator, SBIRT Program, Wishard Health Services, Indianapolis, IN
David Crabb, MD , Department of Medicine, Indiana University School of Medicine, Indianapolis, IN
Mallori DeSalle, MA, LMHC, NCC, CPP , School of Public Health, Indiana University, Bloomington, Indiana Prevention Resource Center, Bloomington, IN
Roland Gamache, PhD, MBA , Regenstrief Institute, Indianapolis, IN
Russell K. McIntire, PhD, MPH , Indiana University School of Public Health-Bloomington, Indiana Prevention Resource Center, Bloomington, IN
Lisa Session, BSW , Midtown Community Mental Health Center, Indianapolis, IN
David Tidd, BS , Indiana Prevention Resource Center, Bloomington, IN
Julie Vannerson, MD , Department of Medicine, Indiana University School of Medicine, Indianapolis, IN
Cynthia Wilson, RN , Midtown Community Mental Health Center, Indianapolis, IN
James Wolf, MA , School of Public Health, Indiana University, Bloomington, Indiana Prevention Resource Center, Bloomington, IN
Ruth Gassman, PhD , School of Public Health, Indiana University, Bloomington, Indiana Prevention Resource Center, Bloomington, IN
The co-occurrence of problematic alcohol use and depression among the primary patient population in the United States is well-documented. However, meta analytic studies identify few instances of comorbidity research using screening instruments. Identifying the existence of such a comorbidity is important because the disorders may causally interact and prevent patient improvement. This study explored the use of standardized screening tools (AUDIT and PHQ-9) to identify and address comorbidities between problematic alcohol use and depression by examining a sample of 10,268 primary care patients at five community health centers. Each patient was prescreened for alcohol use and depression, and “positive” patients completed the appropriate full screening instrument(s). We used one-way ANOVA analyses and Tukey's post-hoc test to compare patients who prescreened negative for alcohol and those scoring in each of the AUDIT's four diagnostic zones in order to assess differences in the prevalence and severity of depression by patients' level of alcohol use. We observed significantly higher levels of depression among patients who scored in any zone on the AUDIT than among those who prescreened negative for alcohol. We also found that the severity of depression was higher among patients scoring in zone IV on the AUDIT than among those scoring in zone I. Screening for alcohol use and depression effectively can identify comorbidities, and may be beneficial to implement in primary care sites where care coordination is possible, especially those implementing screening, brief intervention, and referral to treatment (SBIRT). Further research on patient outcomes in this area is warranted.

Learning Areas:
Planning of health education strategies, interventions, and programs
Provision of health care to the public
Public health or related research

Learning Objectives:
Discuss the utility of the AUDIT and PHQ-9 screening tools in identifying potential comorbidities of problematic alcohol use and depression. Describe the conditions in which it is appropriate to implement screening for problematic alcohol use and depression in a primary care setting.

Keywords: Screening Instruments, Substance Abuse Assessment

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have more than 15 years experience on various research and development projects in the health and health behavioral fields as well as serving as a PI or project leader on multiple multi-year SBIRT related efforts. For this abstract, I have served on the advisory panel and directed educational and behavioral components of the project.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.